Smartphone App Fails FTC Test On Measuring Blood Pressure
This article was originally published in The Pink Sheet
Executive Summary
A settlement with "Instant Blood Pressure App" marketer Aura Labs marks FTC's latest enforcement against firms marketing OTC devices that make unsubstantiated health claims.
You may also be interested in...
Two Acne-Zapping Smartphone Apps Shut Down; FTC On Lookout For Others
Smartphones can do a lot of things, but curing acne is likely not one of them.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.